CLINICAL_TRIALS
trial_result
· 2021-09-16
Clinical Trial Update: Concentration-Controlled Ribavirin for the Treatment of Patients With Chronic Hepatitis C Virus Infection [Phase 4]
Summary
Phase 4 trial update on concentration-controlled ribavirin for chronic hepatitis C virus infection has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Colorado, Denver | Conditions: Hepatitis C Virus | Phase 4 | Status: COMPLETED | Results posted: 2021-09-16